Clinical Trials Logo

Clinical Trial Summary

Prior research has indicated that stereotactic body radiotherapy (SBRT) can effectively trigger systemic anti-tumor immune response. The goal of this observational study is to learn about abscopal effects of stereotactic body radiotherapy in patients of metastatic clear renal cell carcinoma. The primary objective was to assess the objective response rate (ORR) and complete response (CR) in non-irradiated lesions, and incidence of adverse events (AEs).


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT06327178
Study type Observational
Source Nanfang Hospital, Southern Medical University
Contact Guozhu Xie
Phone 02062787693
Email xieguozhu@126.com
Status Recruiting
Phase
Start date October 1, 2023
Completion date April 30, 2024